Cargando…
Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive Enterobacteriaceae in vitro
NDM-1-positive Enterobacteriaceae have caused serious clinical infections, with high mortality rates. Carbapenem was the ultimate expectation for the treatment of such infections in clinical practice. However, since the discovery of plasmid-mediated New Delhi metallo-β-lactamase-1 (NDM-1), the effic...
Autores principales: | Wang, Yanling, Sun, Xiaodi, Kong, Fanrong, Xia, Lining, Deng, Xuming, Wang, Dacheng, Wang, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143545/ https://www.ncbi.nlm.nih.gov/pubmed/32213926 http://dx.doi.org/10.3390/ijerph17062162 |
Ejemplares similares
-
PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1
por: Li, Xiaohui, et al.
Publicado: (2023) -
Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase
por: Liu, Shui, et al.
Publicado: (2018) -
Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae
por: Mulla, Summaiya, et al.
Publicado: (2016) -
Identification of Plasmid-Encoded sRNAs in a bla(NDM-1)-Harboring Multidrug-Resistance Plasmid pNDM-HK in Enterobacteriaceae
por: Kong, Hoi-Kuan, et al.
Publicado: (2018) -
Discovery of a Novel Natural Allosteric Inhibitor That Targets NDM-1 Against Escherichia coli
por: Yang, Yanan, et al.
Publicado: (2020)